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Hemodialysis is associated with an increased risk of
neoplasms which may result, at least in part, from exposure
to ionizing radiation associated with frequent radiographic
procedures. In order to estimate the average radiation
exposure of those on hemodialysis, we conducted a
retrospective study of 100 patients in a university-based
dialysis unit followed for a median of 3.4 years. The number
and type of radiological procedures were obtained from a
central radiology database, and the cumulative effective
radiation dose was calculated using standardized, procedure-
specific radiation levels. The median annual radiation dose
was 6.9 millisieverts (mSv) per patient-year. However, 14
patients had an annual cumulative effective radiation dose
over 20mSv, the upper averaged annual limit for
occupational exposure. The median total cumulative effective
radiation dose per patient over the study period was
21.7mSv, in which 13 patients had a total cumulative
effective radiation dose over 75mSv, a value reported to be
associated with a 7% increased risk of cancer-related
mortality. Two-thirds of the total cumulative effective
radiation dose was due to CT scanning. The average radiation
exposure was significantly associated with the cause of end-
stage renal disease, history of ischemic heart disease,
transplant waitlist status, number of in-patient hospital days
over follow-up, and death during the study period. These
results highlight the substantial exposure to ionizing
radiation in hemodialysis patients.
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Maintenance hemodialysis is associated with an increased
incidence of cancer, the etiology of which is unclear.1,2 A well-
established risk factor for development of cancer is exposure
to environmental or occupational sources of ionizing
radiation. The association of ionizing radiation with cancer
risk is continuous and graded over the entire range of
exposure doses. It is estimated that of a thousand people
exposed to a single 10 millisievert (mSv) effective radiation
dose, one will develop a radiation-related cancer over his/her
lifetime.3 As a result, the radiation exposure of medical
personnel working in radiology departments is carefully
regulated and proactively monitored. The same is not true for
patients, presumably due to the belief that they are unlikely
to suffer ongoing substantial exposure to medical sources of
radiation. Recently, concerns have been raised regarding the
potential harmful effects of ionizing radiation arising from
medical investigations, both within the general population,4
and especially in those with chronic illness who may require
repeated radiological investigations over many years.5
Patients on hemodialysis, in many cases from an early age,
are exposed to a wide range of radiological procedures for
both diagnostic and therapeutic purposes; yet, to date there
have been virtually no published data on the cumulative
radiation exposure that this population accrues over time or
consideration of its potential health consequences. We
therefore conducted the following retrospective study to
quantify the cumulative exposure to ionizing radiation in
patients with end-stage kidney disease (ESKD) treated with
maintenance hemodialysis and to compare this with well-
established thresholds for exposure to ionizing radiation in
occupational settings.
RESULTS
The 100 study subjects were followed for a median of 3.4
years and a total of 345 patient-years of follow-up; 12% had
o1 year of follow-up and 31% were followed for 45 years.
Mean (s.d.) age at study entry was 59 (16.4) years; 34% of
subjects were women and 23% had diabetes (Table 1). All
subjects were Caucasian. In all, 22% of subjects were
prevalent with a median (intra-quartile range (IQR)) dialysis
vintage of 1.8 (1.0–4.3) years, and the remainder initiated
dialysis during the study period. The commonest etiology of
http://www.kidney-international.org o r ig ina l a r t i c l e
& 2010 International Society of Nephrology
Received 5 February 2010; revised 30 April 2010; accepted 4 May 2010;
published online 30 June 2010
Preliminary results from this study were presented at the Irish Nephrology
Society Scientific Meeting, Dublin in May 2010.
Correspondence: Joseph A. Eustace, Department of Nephrology, Cork
University Hospital, Wilton, Cork, Ireland. E-mail: joseph.eustace@hse.ie
Kidney International (2010) 78, 789–793 789
ESKD was chronic glomerulonephritis (28%). At the most
recent time point on dialysis, 51% were dialyzed through a
tunneled catheter, 47% through an arteriovenous fistula, and
only 2 subjects through an arteriovenous graft. Over the
study period, the 100 patients spent a total of 6668 days
admitted to hospital. The median (IQR) percentage of study
total follow-up period per patient spent as a hospital in-
patient was 3.5% (0.9–8.4%). In all, 14 patients died during
the study period, and 47 were on the transplant waitlist, of
whom 4 were transplanted.
A total of 97% of study patients underwent at least one
procedure involving exposure to ionizing radiation and 66%
had at least 1 computed tomography (CT) study during the
study period. Overall, a total of 2575 radiological procedures
were performed, equivalent to approximately 1 procedure for
every 50 patient days of follow-up, and totaling 3423 mSv of
ionizing radiation. The median (range) number of radi-
ological procedures was 7.3 (0–54) per patient-year, including
a median (range) of 0.5 (0–1.6) CT scans per patient-year.
The median estimated total cumulative effective dose
(CED; IQR) per subject over the study period was 21.7 mSv
(4.1–54.5; Figure 1). Of the subjects, 26% had a total CED
450 mSv and 13% had 475 mSv. The proportion of total
radiation exposure attributable to different types of investi-
gations is shown in Table 2. Although comprising only 11.8%
of the total number of radiological procedures, CT scanning
resulted in 66.3% of the total radiation exposure. Vascular
access-related imaging gave rise to 14% of the total CED.
The median (IQR) annual CED per patient-year was
6.9 mSv (1.9–17.4). The percentage of subjects with a CED
per patient-year in excess of 10 and 20 mSv was 37 and 14%,
respectively. Average radiation exposure was not significantly
different for men and women or by age tertile (Table 3).
Median annual CED in those on the transplant waitlist was
significantly lower than in those who were not so listed (4.2
vs 10.4 mSv, P¼ 0.004). Of the recorded comorbidities, only
the presence of ischemic heart disease was significantly
associated with a higher CED (Table 1). Higher CED was
significantly correlated with longer in-patient hospital
stays (r¼ 0.556, Po0.001), and with a highly significant
linear test for trend across quartiles of in-patient hospital
days (Figure 2).
DISCUSSION
We show that even over a limited follow-up period,
maintenance hemodialysis patients are exposed to substantial
doses of ionizing radiation. This may represent an under-
appreciated long-term risk factor for malignancy within this
population. The cumulative radiation exposure was approxi-
mately similar in both men and women and across age
tertiles, but differed by cause of ESKD, transplantation
eligibility, presence of ischemic heart disease, and with higher
in-hospital patient stays. The CED observed in relatively
Table 1 | Patient characteristics at study entry and at the end
of follow-up for total study population and for high
(46.9mSv) and low (o6.9mSv) CED of ionizing radiation
dose per patient-year of follow-up
Patient characteristic Total
Low CED
group
High CED
group P-value
N 100 50 50
Study entry
Male 66% 66% 66% 1.0
Age (years), mean (s.d.) 58.9 (16.4) 56.7 (17.3) 61.3 (15.3) 0.2
Cause of ESKD
Diabetes mellitus 12% 2% 22%
Glomerulonephritis 28% 28% 28%
Hereditary nephropathy 12% 16% 8% 0.02
Congenital/reflux 15% 20% 10%
Miscellaneous 33% 34% 32%
Serum albumin (g/dl)
mean (s.d.)
2.87 (0.6) 2.91 (0.5) 2.82 (0.6) 0.5
Hemoglobin (g/dl)
mean (s.d.)
9.8 (1.9) 9.8 (2.2) 9.7 (1.6) 0.9
Over follow-up
Smoking status
Current 15% 14% 16%
Former 29% 24% 34% 0.3
Never 47% 56% 38%
Unknown 9% 6% 12%
Comorbidity
Diabetes mellitus 23% 20% 26% 0.6
Ischemic heart disease 37% 24% 50% 0.01
Congestive heart failure 15% 14% 16% 1.0
Non-skin malignancy 9% 6% 12% 0.4
Cerebrovascular disease 15% 10% 20% 0.3
Peripheral vascular 17% 10% 24% 0.1
COPD 11% 6% 16% 0.2
Renal transplant eligible 47% 58% 36% 0.045
In-patient hospital days,
median (IQR)
38 (13–97) 19 (3–43) 77 (34–160) o0.001
Death 14% 2% 26% 0.001
Abbreviations: CED, cumulative effective radiation dose; COPD, chronic obstructive
pulmonary disease; ESKD, end-stage kidney disease; IQR, intra-quartile range; mSv,
millisieverts.
Miscellaneous etiologies include nephrocalcinosis, ischemic nephropathy, myeloma,
and uncertain.
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Figure 1 |Boxplot showing median (solid line) and intra-
quartile range (box) of average cumulative effective radiation
exposure from radiological procedures in 100 period
prevalent hemodialysis subjects followed for 345 patient-
years. Values outside fence are outliers (J).
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young subjects and those who are transplant eligible may be
of particular concern, given the anticipated life expectancy of
these subjects and the ongoing use of immunosuppressive
agents in the latter.
Although plain radiographs accounted for the majority of
radiological procedures, they accounted for only 6.8% of
total cumulative radiation exposure, which was instead
largely determined by CT and to a lesser extent from vascular
access-related procedures. The radiation exposure from CT
examinations varies not only with the type of CT examina-
tion but also with protocol used and type of equipment used.
Radiation exposure has been shown to vary over a tenfold
range in clinical practice for the same investigation,
depending on these parameters.6 There is a clear rationale
for developing low-dose protocols and minimizing radiation
exposure to the greatest extent possible in high-risk
individuals.
The average effective radiation exposure from background
environmental sources in the United States is estimated to be
o3 mSv per year.7 Occupational restrictions limit annual
Table 2 | Number of radiological procedures, and annual and total cumulative effective radiation dose by procedure type
Number of
tests, N (%)
Annual CED (mSv per
patient-year) median (IQR)
Total CED
mSv (%)
All studies
Overall total 2575 (100%) 6.9 (1.9–17.4) 3423.3 (100%)
Non-dialysis access-related studies
Computed tomography 306 (11.8%) 2.2 (0–12.3) 2269.0 (66.3%)
Plain radiograph 1721 (67%) 0.5 (0.1–1.0) 232.9 (6.8%)
Cardiology procedures 50 (1.9%) 0.0 (0–0.6) 220.7 (6.4%)
Miscellaneous 47 (1.8%) 0.0 (0–0.1) 223.4 (6.5%)
Subtotal 2124 (82.5%) 4.5 (1–15.0) 2945.9 (86%)
Dialysis access-related studies
Catheter-related procedures 290 (11.3%) 0.5 (0.1–1.0) 211.7 (6.2%)
AV fistula-related procedures 161 (6.2%) 0.0 (0.0–1.1) 265.7 (7.8%)
Subtotal 451 (17.5%) 0.9 (0.2–2.6) 477.4 (14%)
Abbreviations: AV, arteriovenous; CED, cumulative effective radiation dose; IQR, intra-quartile range.
Table 3 | CED of ionizing radiation per patient-year of follow-up and over the total study period by age, gender, and total
number of in-patient hospital days in 100 period prevalent hemodialysis subjects
CED (mSv per patient-year) Total CED (mSv)
N Median (IQR) Range Median (IQR) Range
All 100 6.9 (1.9–17.4) 0–78 21.7 (4.1–54.5) 0–149
Male 66 6.9 (2.3–17.5) 0–47.7 20.1 (4.1–48.9) 0–123.6
Female 34 6.6 (1.1–17.1) 0–78 24.1 (3.6–67.2) 0–149
Age (years)
o54 33 5.7 (0.9–16.6) 0–41.7 21.6 (3.8–56.2) 0–149
54–68 33 5.9 (3.0–14.4) 0.5–22.4 17.6 (5.1–63.4) 1–117
468 34 8.4 (3.6–19.5) 0–78 23.3 (7.7–40.9) 0–100
Quartiles of patient in-hospital days
0–13 days 25 1.2 (0.5–4.2) 0–28.5 3.5 (0.9–12.0) 0–94.9
14–38 days 25 4.2 (1.6–13.1) 0.6–31.9 17.3 (3.8–28.8) 1.3–80.8
39–95 days 25 7.4 (5.3–18.4) 1.1–58.7 27.7 (11.0–40.0) 1.7–114.1
96–448 days 25 16.3 (9.0–22.4) 2.9–78.0 63.4 (47.0–92.0) 10.7–149
P linear trend o0.001 o0.001
Abbreviations: CED, cumulative effective radiation dose; IQR, intra-quartile range.
**
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P <0.001, Linear test for trend
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Figure 2 |Boxplots showing median (solid line) and intra-
quartile range (box) of cumulative effective radiation exposure
from radiological procedures per patient-year of follow-up by
quartile of total in-patient hospital days over the follow-up
period. Values outside fence are outliers (J) and extreme outliers (*).
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exposure—averaged over a 5-year period—to o20 mSv per
year and no more than 50 mSv in any one year.8 However,
although the purpose of such guidelines is to limit the
hazards of radiation exposure, there is no lower threshold,
below which radiation exposure can be considered clinically
irrelevant. Instead, the association of ionizing radiation with
cancer risk is continuous and graded over the entire range of
exposure.3 Occupational exposure to a cumulative effective
dose of 75 mSv has been associated with a 7.3% increase in
cancer-specific mortality.9 Within our study, over one-third
of subjects had an effective radiation exposure of 410 mSv
per patient-year of follow-up, whereas one in eight subjects
had a cumulative recorded exposure of 475 mSv and one
subject had almost double this level of exposure. Even if
unavoidable, the potential health consequences of such levels
of exposures should be investigated as a matter of urgency.
Given that the need for radiographic investigation is
dependant on clinical circumstances, there can be no
regulatory upper exposure limit for patients; instead, it is
recommended that the ‘ALARA’ (as low as reasonably
achievable) principle be used when planning radiographic
investigations.10 Unfortunately, many of the radiological
procedures performed on hemodialysis subjects are essential
for the adequate evaluation of acute medical problems or for
the management of access-related problems. However,
awareness of the extent of radiation exposure should be
one element considered in the diagnostic and therapeutic
decision-making process and to allow for adequate informed
consent by the patient. This becomes especially important in
elective investigations or in research settings. As each
individual radiological procedure only augments the cumu-
lative risk to a minor extent, immediate consideration should
be given to the development of systems to continuously and
prospectively monitor the CED of patients with chronic
illness such as ESKD, as is mandated in occupational settings.
Given the dominant effect of CT studies on cumulative
exposure, the number and type of previous CT studies that a
subject has received can be useful as a more readily available
indicator of previous radiation exposure. A simple first step
in prospective monitoring of radiation exposure could be the
recording on the radiological report the estimated effective
radiation exposure in mSv associated with the procedure.
The proactive monitoring of cumulative exposure to medical
sources of ionizing radiation may serve to increase awareness
of its potential consequences, to minimize nonessential
exposure, or to use alternative imaging strategies (such as
ultrasound or non-gadolinium-enhanced magnetic resonance
imaging techniques), and to intervene on potentially
modifiable alternative cancer risk factors such as domestic
radon exposure or tobacco smoking; it may also encourage
uptake in appropriate cancer screening programs.
Several limitations apply to our study. It was conducted in
a single center, whereas the cumulative radiation dose will
tend to vary with differences in clinical practice pattern—
especially regarding use of CT and vascular access-related
procedures. In particular, centers with a high proportion of
arteriovenous grafts and aggressive approaches to assisted
patency may have substantially higher access-related cumu-
lative radiation exposures. Given its retrospective design, we
were obliged to use standardized procedure-specific mean
effective radiation doses to calculate individual CED.
Although imprecise, our results clearly suggest that in many
hemodialysis subjects, cumulative radiation exposure over a
period of several years may reach levels that would be of
clinical concern if occurring in an occupational setting. We
only captured CED during observed period on dialysis and as
performed at the regional medical center for dialysis patients;
this, by definition, underestimates the total lifetime radiation
exposure of the subjects, especially in those with a prolonged
history of illness before initiating dialysis.
In conclusion, maintenance hemodialysis patients under-
go a large and varied number of radiological procedures over
time, with a resulting significant cumulative exposure to
ionizing radiation. The potential health consequences of this
require further urgent investigation as do effective strategies
to minimize this exposure. We believe that as an immediate
measure, the cumulative radiation exposure of the indivi-
duals—at least for CT-related procedures—should be retro-
spectively estimated and prospectively monitored to identify
those who may be at the highest risk of ionizing radiation-
induced adverse events.
MATERIALS AND METHODS
We conducted a retrospective study of period prevalent maintenance
hemodialysis patients attending a single university-based dialysis
center between 1 April 2004 and 31 December 2009; patients with
o6 months of follow-up were excluded. The study protocol was
approved by the clinical research ethics committee of the Cork
Teaching Hospitals. Details of all radiological procedures performed
on patients in the cohort during the study period were obtained
from the Cork University Hospital Department of Radiology
computerized imaging database. As our center is the sole regional
provider of dialysis services—regardless of insurance status—
hemodialysis subjects are either preferentially referred for admission
to it or are rapidly transferred to it if presenting elsewhere. All CT
scans were performed using either a single-slice CT (Siemens
Medical Solutions, Erlangen Germany) or a four-detector CT
(Toshiba Aquilon, Toshiba Medical Systems, Zoetermeer, The
Netherlands).
The overall detrimental biological effect of ionizing radiation
exposure was quantified using the CED in mSv.11 This is calculated
from the sum of the absorbed dose (in Grays) to differentially
radiosensitive tissues, weighted according to the aggregated risk of
health detriment for the whole population.12 We calculated CED for
all of the radiological procedures performed during the study period
using average procedure-specific effective doses published by the UK
National Radiation Protection Board, 200113 (Table 4). As this does
not provide specific estimates for dialysis access-related procedures,
the estimated CED for dialysis catheter insertion was based on that
reported for Hickman catheter insertion; the published CED for
superior venocavography was used for central venoplasty, and the
CED of a superior venocavagram and upper limb venogram
combined was used for fistulogram and fistuloplasty. The estimated
CEDs for central venoplasty and dialysis fistuloplasty are very likely
792 Kidney International (2010) 78, 789–793
or ig ina l a r t i c l e SM Kinsella et al.: Cumulative ionizing radiation exposure in HD
to be underestimates, but the small overall number of these
procedures means that these estimates are unlikely to affect total
CED.
The total CED over follow-up and the mean CED per patient-
year were calculated for each patient. To assess the factors associated
with higher radiation exposure, demographic and clinical char-
acteristics were compared in groups exposed to high and low levels
of radiation, defined using the median study CED per patient-year.
Laboratory values were obtained at initiation of dialysis for incident
patients and at the first routine monthly blood draw occurring
within the study period for prevalent patients. The clinically
attributed cause of ESKD was obtained from our dialysis registry.
It is our practice to record the etiology of ESKD as ‘uncertain’ in
subjects who are without an adequate renal biopsy, history of
substantial proteinuria, or diagnostic serological tests, regardless of
the presence of hematuria or hypertension; although in many
of such cases there may be a clinical suspicion of chronic
glomeruloneohritis or hypertensive/ischemic nephropathy as their
most likely etiology. Recorded comorbidities and cigarette smoking
status was obtained by review of clinic letters, discharge summaries,
and the patient medical notes as of the end of study follow-up.
Ischemic heart disease was defined as documented presence of
angina, previous myocardial infarction, positive cardiac investiga-
tion, or need for coronary interventions. The in-patient hospital
days were used as a combined surrogate for acute illness
and comorbidities and were calculated from the computerized
hospital admission record and categorized into quartiles of its
distribution.
Statistical considerations
Data were described using mean and s.d. or for nonparametric
distributions using median and IQR. Comparison between groups
was performed using Fisher’s exact test for categorical variables and
Mann–Whitney U-test or Kruskal–Wallis test for nonnormally
distributed continuous variables with two or more than two groups,
respectively. Bivariate correlations were measured using Spearman’s
rank method. Analyses were performed using Statistical Package for
Social Analysis, Version 16.0 software (Chicago, IL, USA) using a
two-sided type 1 error rate of 0.05.
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